Jonatan D Lindh

Author PubWeight™ 22.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The largest prospective warfarin-treated cohort supports genetic forecasting. Blood 2008 2.79
2 Impact of cytochrome P450 2C19 polymorphisms on citalopram/escitalopram exposure: a systematic review and meta-analysis. Clin Pharmacokinet 2014 2.08
3 Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One 2013 1.53
4 A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele. Pharmacogenomics 2012 1.42
5 Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. Thromb Haemost 2011 1.35
6 Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open 2012 1.34
7 Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis. J Psychopharmacol 2010 1.22
8 Statin treatment and mortality in bacterial infections--a systematic review and meta-analysis. PLoS One 2010 1.05
9 What is a relevant statin concentration in cell experiments claiming pleiotropic effects? Br J Clin Pharmacol 2011 1.00
10 Therapeutic drug monitoring for tomorrow. Eur J Clin Pharmacol 2013 0.95
11 Pharmacogenetics of anticoagulants. Hum Genomics Proteomics 2010 0.84
12 Plasma levels of 25-hydroxyvitamin D3 and in vivo markers of cytochrome P450 3A activity in Swedes and Koreans: effects of a genetic polymorphism and oral contraceptives. Basic Clin Pharmacol Toxicol 2014 0.82
13 CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients. Pharmacogenomics 2013 0.80
14 Serum levels of 25-hydroxyvitamin D and the CYP3A biomarker 4β-hydroxycholesterol in a high-dose vitamin D supplementation study. Drug Metab Dispos 2013 0.80
15 Increased liability of tramadol-warfarin interaction in individuals with mutations in the cytochrome P450 2D6 gene. Eur J Clin Pharmacol 2004 0.80
16 Possible drug-drug interaction between quetiapine and lamotrigine--evidence from a Swedish TDM database. Br J Clin Pharmacol 2011 0.79
17 Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome. Ther Drug Monit 2007 0.78
18 Prevalence of Therapeutic Drug Monitoring for Antidepressants and Antipsychotics in Stockholm, Sweden: A Longitudinal Analysis. Ther Drug Monit 2015 0.78
19 Direct and efficient liquid chromatographic-tandem mass spectrometric method for opiates in urine drug testing - importance of 6-acetylmorphine and reduction of analytes. Drug Test Anal 2013 0.77
20 Comment: patient-specific factors predictive of warfarin dosage requirements. Ann Pharmacother 2003 0.75
21 Extreme Duration of Diazepam-Associated Sedation in a Patient With Alcohol Delirium and CYP2C19 Polymorphisms. J Clin Psychopharmacol 2015 0.75
22 Severely diminished response to vitamin K-treatment for self-inflicted warfarin intoxication in a patient genotyped as CYP2C9*3*3. Eur J Clin Pharmacol 2009 0.75
23 Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing Genotype. Ther Drug Monit 2016 0.75